LumiraDx Platform
Next-generation point of care diagnostic platform - Next-generation microfluidic technology on the LumiraDx Platform enables lab-comparable performance across a broad menu of diagnostic assays.
LumiraDx
LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. As industry leading innovators, we have developed a next-generation point of care Platform, that is transforming community-based healthcare. Our technology provides fast, high performance and accessible diagnostic solutions at the point of need.
NT-proBNP Test
The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP in human capillary and venous whole blood and plasma samples (Lithium Heparin). Use...
D-Dimer Test
The LumiraDx D-Dimer Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify D-Dimer levels in whole blood and plasma. It is the only direct fingerstick D-Dimer assay avail...
HbA1C Test
The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c ...
INR Test
The LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample – all in less than 90 seconds*. The Test is used for mo...
Browse Products by Field
LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. As industry leading innovators, we have developed a next-generation point of care Platform, that is transforming community-based healthcare. Our technology provides fast, high performance and accessible diagnostic solutions at the point of need.